ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

IJMDC. 2026; 10(7): 1958-1973


Antibiotic therapy of infective endocarditis in hemodialysis patients: a systematic review and meta analysis

Hind Khalid Goresh.



Abstract
Download PDF Post

Background: Infective endocarditis (IE) is a serious and life-threatening infection that carries high morbidity and mortality, particularly among patients undergoing hemodialysis (HD). Repeated vascular access, frequent healthcare exposure, and multiple comorbidities increase the susceptibility of HD patients to bloodstream infections that may progress to IE. Although antibiotic therapy remains the cornerstone of treatment, evidence regarding treatment outcomes in this population remains scattered. This systematic review and meta-analysis aimed to evaluate the effectiveness and outcomes of antibiotic therapy for IE among HD patients.
Methods: This systematic review and meta-analysis were conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. A comprehensive literature search was performed in PubMed/MEDLINE, Cochrane Library, DOAJ, and Google Scholar from database inception to the latest available date. Studies involving adult HD patients diagnosed with IE and treated with systemic antibiotic therapy were included. Observational studies, cohort studies, and case series with ≥10 patients were eligible. Data extraction was performed independently by two reviewers using a standardized form. Key outcomes included mortality, clinical cure, relapse rates, and treatment characteristics. Pooled proportions were calculated using a random-effects model, and heterogeneity was assessed using the I² statistic.
Results: Twelve studies involving 325,320 HD patients were included in the analysis. The pooled prevalence of IE among HD patients was 49% (95% CI: 23-75) with substantial heterogeneity (I² = 100%). The pooled clinical cure rate after antibiotic therapy was 59% (95% CI: 39-80) with no heterogeneity (I² = 0%, p = 0.649). The relapse rate was relatively low at 4% (95% CI: 0-11) but showed moderate heterogeneity (I² = 78.6%, p = 0.009). Despite treatment, pooled mortality remained high at 41% (95% CI: 33-50) with significant heterogeneity (I² = 85%, p < 0.001). Mortality was higher with treatment duration

Key words: Infective Endocarditis; Hemodialysis; Antibiotic Therapy; Chronic Kidney Disease; Systematic Review and Meta-analysis







Bibliomed Article Statistics

6
R
E
A
D
S


D
O
W
N
L
O
A
D
S
07
2026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.